?? Exciting moments at American Association for the Study of Liver Diseases (AASLD): The Liver Meeting in San Diego, CA! ?? Dr. Jeannie Lucas and Dr. Samir Arora represented Centricity Research with passion and expertise this year. Together, they are paving the way for advancements in liver disease research and patient care. From connecting with global experts to exploring cutting-edge innovations, it’s inspiring to see such dedication to improving lives and advancing therapies. At Centricity, we aspire to place liver patients and partners at the center of innovation. Events like this remind us how impactful collaboration and shared knowledge can be. Here's to pushing the boundaries of what’s possible in liver research! #AASLD2024 #LiverResearch #PatientCenteredInnovation #CentricityResearch #AdvancingTherapies | Lucas Research | Aventiv Research (Now Centricity Research) | True North Clinical Research (Now Centricity Research) | IACT Health (Now Centricity Research)
关于我们
Centricity Research is an integrated research organization (IRO) with more than 40 wholly owned and integrated clinical research offices across North America. The company conducts Phase I-IV clinical research in over 35 therapeutic areas: inpatient and outpatient; pharmaceutical, biotechnology, and medical device trials. For more than 25 years, the organization’s founders have worked to revolutionize research by investing in the people and technology needed to deliver outstanding clinical trial experiences, earning numerous awards including “Best Places to Work” and recognition for “Outstanding Diversity in Clinical Research.” Jobseekers: Apply here >> https://centricityresearch.applytojob.com/apply
- 网站
-
https://www.centricityresearch.com/
Centricity Research的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Columbus，Georgia
- 类型
- 私人持股
- 领域
- Clinical Research、Primary Care、Phase I to IV、Drug Development、Clinical Trials、Clinical Studies和Biotechnology
地点
Centricity Research员工
动态
-
ObesityWeek? kicks off this Sunday in San Antonio and our team is excited to see you there! Book a meeting with Samir Arora or Brittany Irvin to learn more about the #clinicalresearch we've taken on in the obesity space, our numerous #clinicaltrial successes, and our capabilities for future studies. Looking forward to a productive conference!
-
-
We're taking a little trip across the pond in just a few weeks to attend The World Vaccine Congress Europe in beautiful Barcelona, Spain! If you're attending, book a meeting with our Chief Operating Officer Alexandra Walton or Chief Growth Officer Samir Arora and learn more about the work we're doing in the vaccine space. #worldvaxeurope
-
-
Feels like we are still trying to recover from the hustle and bustle that was this year’s Society for Clinical Research Sites (SCRS) Global Summit! Another fantastic conference in the books. Some highlights— ??Director of Growth & Strategic Partnerships, Lydia Beaudette offered some key insights on scaling beyond one location and how to best manage that growth. ?? Senior Marketing Specialist Kayra L. Velez, BBA shared best practices for study advertising on social media with a fun, Jeopardy-style twist. ?? Business Development Manager Brittany Irvin provided useful tips and tricks for how sites can stand out during the feasibility process and have a better chance at being selected for studies. Congratulations to all of this year’s award winners, and thank you to everyone who made this conference a productive and enjoyable experience. Looking forward to next year!
-
-
We are so excited to be at this year's Society for Clinical Research Sites (SCRS) Site Solutions Summit at the end of the month, and we can't wait to see you there! Our COO Alexandra Walton, Executive Director of Business Development Felicia Irvin, Business Development Manager Brittany Irvin, Director of Growth & Strategic Partnerships Lydia Beaudette, and Senior Marketing Specialist Kayra L. Velez, BBA will all be in attendance. In addition, several will be speaking on panel sessions throughout the weekend (more details in our next post). Looking forward to seeing old faces, connecting with new colleagues, and talking all things #clinicalresearch! #scrs2024
-
-
Today, we celebrate the hard work, dedication, and resilience of our amazing staff and #clinicaltrial participants. Your efforts are crucial in advancing medical research and bringing new treatments to those who need them most. Let’s take a moment to honor the impact of every individual who contributes to making a difference. Enjoy a well-deserved day of rest and reflection! Happy #LaborDay to all of you!
-
-
Congrats to Moderna, Pfizer, and the whole team at Centricity Research for the recent FDA approval of the latest COVID-19 vaccine! It's easy to move past this milestone quickly and forget the immense impact that the COVID-19 vaccine has had on global health. This is a significant achievement that we all should be proud of. For example, an analysis by the Commonwealth Fund found that the COVID-19 vaccine, since its first administration in the U.S., has demonstrated its potential by preventing more than 18 million hospitalizations and more than 3 million deaths. This underscores the importance of our collective efforts in the fight against global pandemics.
-
-
It’s officially a wrap on this year’s ADA Scientific Sessions, and what a successful conference! Our team debuted a brand new booth build alongside our newly launched #whyifight campaign, made some valuable connections, and learned about some cutting edge therapies and molecules for #diabetes treatment. American Diabetes Association, we’ll see you next year in Chicago for the 85th Scientific Sessions!
-
-
????Announcing the winner of our $500 Amazon Gift Card— Barbara Arispe of QCR Network! ???? Barbara’s story of why she fights to advance #clinicalresearch is truly touching. She originally got into the industry after her mother passed away from Hepatitis C, an event that really inspired her to seek out change for the future of medicine. As she continued to progress through her career, she was able to work on the HAVOI Hepatitis C studies that absolutely changed the landscape of care for people with the disease. Her mother’s memory continues to inspire her to keep pushing forward. ?? Thank you to Barbara and the rest of our contest entrants for sharing your stories with us. We enjoyed talking to each of you! If you didn’t get a chance to see us and want to share your story, share it on LinkedIn using the hashtag #whyifight, and let’s create a movement!
-
-
Day 2 of poster presentations at American Diabetes Association 84th Scientific Sessions was a success! Dr. Kathryn Jean Lucas presented findings from the Akero Therapeutics HARMONY studies on patients with MASH and Type 2 diabetes, and Dr. Bajaj presented results from Eli Lilly and Company SURPASS studies exploring tirzepatide and Lexicon Therapeutics SOTA-INS studies on sotagliflozin. For complete poster information and study findings: ? Insulin-Sensitizing Effects of Efruxifermin Improve Glycemic Control in Patients with MASH and Type 2 Diabetes: https://lnkd.in/gqQhsxCH ? Tirzepatide as an Add-On for Participants With Inadequate Glycemic Control Using Basal Insulin: Pooled Subgroup Analysis of SURPASS-5 and -6: https://lnkd.in/eJYfk_bP ? Impact of Sotagliflozin, a Dual Sodium–Glucose Cotransporter 1/2 Inhibitor, as Add-on to Inadequately Controlled Basal Insulin–Treated Type 2 Diabetes: https://lnkd.in/gqQhsxCH #clinicalresearch #diabetesresearch #MASH
-